Literature DB >> 12458612

Percutaneous arterial embolization and chemoembolization for treatment of benign and malignant tumors in three dogs and a goat.

Chick Weisse1, Craig A Clifford, David Holt, Jeffrey A Solomon.   

Abstract

The term bland arterial embolization refers to catheter-directed delivery of particulate material for the purpose of embolizing selected arteries. This technique is used in humans to treat a number of conditions, including arteriovenous malformations, uterine fibroids, and epistaxis. The term chemoembolization refers to selective intra-arterial delivery of chemotherapeutic agents in conjunction with particulate material for the purpose of embolizing arteries supplying blood to a tumor. Compared with traditional modes of drug delivery, chemoembolization increases local concentration and dwell time of the chemotherapeutic agent, augments tumor ischemia, and minimizes systemic toxic effects. In humans, the technique has shown encouraging results in the treatment of a variety of nonresectable tumors. The present report describes techniques for percutaneous bland arterial embolization and chemoembolization in dogs and goats and results of these techniques in 3 dogs and a goat. Bland arterial embolization was performed in 2 dogs and the goat. The goals of treatment included pain palliation, reduction of tumor growth, and control of hemorrhage, and each animal was considered to have benefited from the procedure on the basis of the preprocedural goals. Chemoembolization was performed in 1 dog for treatment of a nonresectable hepatocellular carcinoma. Unfortunately, this dog did not live long enough to identify any response to treatment. Results for animals studied illustrate the feasibility of bland arterial embolization and chemoembolization in veterinary patients and suggest that embolization may provide an alternative method of treatment for animals with inoperable lesions.

Entities:  

Mesh:

Year:  2002        PMID: 12458612     DOI: 10.2460/javma.2002.221.1430

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  10 in total

1.  Transcatheter glue arterial embolization of a mass in the hind limb of a dog.

Authors:  Guillaume de La Villeon; Arnaud Louvet; Luc Behr; Nicolas Borenstein
Journal:  Can Vet J       Date:  2011-03       Impact factor: 1.008

2.  Factors associated with long-term survival in dogs undergoing liver lobectomy as treatment for liver tumors.

Authors:  Jessica R Kinsey; Stephen D Gilson; Joe Hauptman; Steve J Mehler; Lauren R May
Journal:  Can Vet J       Date:  2015-06       Impact factor: 1.008

3.  Identification of rhodamine 123-positive stem cell subpopulations in canine hepatocellular carcinoma cells.

Authors:  Harumichi Itoh; Shimpei Nishikawa; Tomoya Haraguchi; Yu Arikawa; Masato Hiyama; Toshie Iseri; Yoshiki Itoh; Munekazu Nakaichi; Yasuho Taura; Kenji Tani; Kazuhito Itamoto
Journal:  Biomed Rep       Date:  2017-06-07

Review 4.  Histotripsy Ablation in Preclinical Animal Models of Cancer and Spontaneous Tumors in Veterinary Patients: A Review.

Authors:  Alissa Hendricks-Wenger; Lauren Arnold; Jessica Gannon; Alex Simon; Neha Singh; Hannah Sheppard; Margaret A Nagai-Singer; Khan Mohammad Imran; Kiho Lee; Sherrie Clark-Deener; Christopher Byron; Michael R Edwards; Martha M Larson; John H Rossmeisl; Sheryl L Coutermarsh-Ott; Kristin Eden; Nikolaos Dervisis; Shawna Klahn; Joanne Tuohy; Irving Coy Allen; Eli Vlaisavljevich
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2021-12-31       Impact factor: 3.267

5.  Evaluation of hepatic tumor portal perfusion using mesenteric angiography: A pilot study in 5 dogs.

Authors:  Kelsey Goode; Chick Weisse; Allyson Berent; Ken Lamb
Journal:  J Vet Intern Med       Date:  2018-12-18       Impact factor: 3.333

6.  Drug-eluting bead chemoembolization for the treatment of nonresectable hepatic carcinoma in dogs: A prospective clinical trial.

Authors:  Cleo P Rogatko; Chick Weisse; Tobias Schwarz; Allyson C Berent; Marcio A Diniz
Journal:  J Vet Intern Med       Date:  2021-05-06       Impact factor: 3.333

7.  Effect of drug-eluting bead transarterial chemoembolization loaded with cisplatin on normal dogs.

Authors:  Ko Nakasumi; Naoki Yamamoto; Taro Takami; Harumichi Itoh; Kazuhito Itamoto; Hiro Horikirizono; Toshie Iseri; Munekazu Nakaichi; Yuki Nemoto; Hiroshi Sunahara; Kenji Tani
Journal:  J Vet Med Sci       Date:  2021-12-06       Impact factor: 1.267

8.  Evaluation of the use of a novel bioabsorbable polymer drug-eluting microsphere for transarterial embolization of hepatocellular neoplasia in dogs.

Authors:  William T N Culp; Eric G Johnson; Michelle A Giuffrida; Robert B Rebhun; James K Cawthra; Heidi A Schwanz; Jenna H Burton; Michael S Kent
Journal:  PLoS One       Date:  2022-08-08       Impact factor: 3.752

Review 9.  Comparative Oncology: Management of Hepatic Neoplasia in Humans and Dogs.

Authors:  Erin A Gibson; Roger E Goldman; William T N Culp
Journal:  Vet Sci       Date:  2022-09-08

10.  Pharmacokinetic study comparing doxorubicin concentrations after chemoembolization or intravenous administration in dogs with naturally occurring nonresectable hepatic carcinoma.

Authors:  Nina Samuel; Chick Weisse; Allyson C Berent; Cléo P Rogatko; Luke Wittenburg; Kenneth Lamb
Journal:  J Vet Intern Med       Date:  2022-08-16       Impact factor: 3.175

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.